recombinant DNA technology

recombinant DNA technology
any of various techniques for separating and recombining segments of DNA or genes, often employing a restriction enzyme to cut a gene from a donor organism and inserting it into a plasmid or viral DNA for transplantation into a host organism, where the gene causes the production of a desired substance either for harvesting or for the benefit of the host organism itself. Also called gene splicing.

* * *

 joining together of DNA molecules from two different species that are inserted into a host organism to produce new genetic combinations that are of value to science, medicine, agriculture, and industry. Since the focus of all genetics is the gene, the fundamental goal of laboratory geneticists is to isolate, characterize, and manipulate genes. Although it is relatively easy to isolate a sample of DNA from a collection of cells, finding a specific gene within this DNA sample can be compared to finding a needle in a haystack. Consider the fact that each human cell contains approximately 2 metres (6 feet) of DNA. Therefore, a small tissue sample will contain many kilometres of DNA. However, recombinant DNA technology has made it possible to isolate one gene or any other segment of DNA, enabling researchers to determine its nucleotide sequence, study its transcripts, mutate it in highly specific ways, and reinsert the modified sequence into a living organism.

DNA cloning (clone)
 In biology a clone is a group of individual cells or organisms descended from one progenitor. This means that the members of a clone are genetically identical, because cell replication produces identical daughter cells each time. The use of the word clone has been extended to recombinant DNA technology, which has provided scientists with the ability to produce many copies of a single fragment of DNA, such as a gene, creating identical copies that constitute a DNA clone. In practice the procedure is carried out by inserting a DNA fragment into a small DNA molecule and then allowing this molecule to replicate inside a simple living cell such as a bacterium. The small replicating molecule is called a DNA vector (carrier). The most commonly used vectors are plasmids (circular DNA molecules that originated from bacteria), viruses, and yeast cells. Plasmids are not a part of the main cellular genome, but they can carry genes that provide the host cell with useful properties, such as drug resistance, mating ability, and toxin production. They are small enough to be conveniently manipulated experimentally, and, furthermore, they will carry extra DNA that is spliced into them.

Creating the clone
      The steps in cloning are as follows. DNA is extracted from the organism under study and is cut into small fragments of a size suitable for cloning. Most often this is achieved by cleaving the DNA with a restriction enzyme. Restriction enzymes are extracted from several different species and strains of bacteria, in which they act as defense mechanisms against viruses. They can be thought of as “molecular scissors,” cutting the DNA at specific target sequences. The most useful restriction enzymes make staggered cuts; that is, they leave a single-stranded overhang at the site of cleavage. These overhangs are very useful in cloning because the unpaired nucleotides will pair with other overhangs made using the same restriction enzyme. So, if the donor DNA and the vector DNA are both cut with the same enzyme, there is a strong possibility that the donor fragments and the cut vector will splice together because of the complementary overhangs. The resulting molecule is called recombinant DNA. It is recombinant in the sense that it is composed of DNA from two different sources. Thus, it is a type of DNA that would be impossible naturally and is an artifact created by DNA technology.

      The next step in the cloning process is to cut the vector with the same restriction enzyme used to cut the donor DNA. Vectors have target sites for many different restriction enzymes, but the most convenient ones are those that occur only once in the vector molecule. This is because the restriction enzyme then merely opens up the vector ring, creating a space for the insertion of the donor DNA segment. Cut vector DNA and donor DNA are mixed in a test tube, and the complementary ends of both types of DNA unite randomly. Of course, several types of unions are possible: donor fragment to donor fragment, vector fragment to vector fragment, and, most important, vector fragment to donor fragment, which can be selected for. Recombinant DNA associations form spontaneously in the above manner, but these associations are not stable because, although the ends are paired, the sugar- phosphate backbone of the DNA has not been sealed. This is accomplished by the application of an enzyme called DNA ligase, which seals the two segments, forming a continuous and stable double helix.

      The mixture should now contain a population of vectors each containing a different donor insert. This solution is mixed with live bacterial cells that have been specially treated to make their cells more permeable to DNA. Recombinant molecules enter living cells in a process called transformation. Usually, only a single recombinant molecule will enter any individual bacterial cell. Once inside, the recombinant DNA molecule replicates like any other plasmid DNA molecule, and many copies are subsequently produced. Furthermore, when the bacterial cell divides, all of the daughter cells receive the recombinant plasmid, which again replicates in each daughter cell.

      The original mixture of transformed bacterial cells is spread out on the surface of a growth medium in a flat dish (Petri dish) so that the cells are separated from one another. These individual cells are invisible to the naked eye, but as each cell undergoes successive rounds of cell division, visible colonies form. Each colony is a cell clone, but it is also a DNA clone because the recombinant vector has now been amplified by replication during every round of cell division. Thus, the Petri dish, which may contain many hundreds of distinct colonies, represents a large number of clones of different DNA fragments. This collection of clones is called a DNA library. By considering the size of the donor genome and the average size of the inserts in the recombinant DNA molecule, a researcher can calculate the number of clones needed to encompass the entire donor genome, or, in other words, the number of clones needed to constitute a genomic library.

      Another type of library is a cDNA library. Creation of a cDNA library begins with messenger ribonucleic acid (mRNA) instead of DNA. Messenger RNA carries encoded information from DNA to ribosomes for translation into protein. To create a cDNA library, these mRNA molecules are treated with the enzyme reverse transcriptase, which is used to make a DNA copy of an mRNA. The resulting DNA molecules are called complementary DNA (cDNA). A cDNA library represents a sampling of the transcribed genes, whereas a genomic library includes untranscribed regions.

      Both genomic and cDNA libraries are made without regard to obtaining functional cloned donor fragments. Genomic clones do not necessarily contain full-length copies of genes. Furthermore, genomic DNA from eukaryotes (cells or organisms that have a nucleus) contains introns, which are regions of DNA that are not translated into protein and cannot be processed by bacterial cells. This means that even full-sized genes are not translated in their entirety. In addition, eukaryotic regulatory signals are different from those used by prokaryotes (cells or organisms lacking internal membranes—i.e., bacteria). However, it is possible to produce expression libraries by slicing cDNA inserts immediately adjacent to a bacterial promoter region on the vector; in these expression libraries, eukaryotic proteins are made in bacterial cells, which allows several important technological applications that are discussed below in DNA sequencing (recombinant DNA technology).

      Several bacterial viruses have also been used as vectors. The most commonly used is the lambda phage. The central part of the lambda genome is not essential for the virus to replicate in Escherichia coli, so this can be excised using an appropriate restriction enzyme, and inserts from donor DNA can be spliced into the gap. In fact, when the phage repackages DNA into its protein capsule, it includes only DNA fragments the same length of the normal phage genome.

      Vectors are chosen depending on the total amount of DNA that must be included in a library. Cosmids are engineered vectors that are hybrids of plasmid and phage lambda; however, they can carry larger inserts than either pUC plasmids (plasmids engineered to produce a very high number of DNA copies but that can accommodate only small inserts) or lambda phage alone. Bacterial artificial chromosomes (BACs) are vectors based on F-factor (fertility factor) plasmids of E. coli and can carry much larger amounts of DNA. Yeast artificial chromosomes (YACs) are vectors based on autonomously replicating plasmids of Saccharomyces cerevisiae (baker's yeast). In yeast (a eukaryotic organism) a YAC behaves like a yeast chromosome and segregates properly into daughter cells. These vectors can carry the largest inserts of all and are used extensively in cloning large genomes such as the human genome.

Isolating the clone
      In general, cloning is undertaken in order to obtain the clone of one particular gene or DNA sequence of interest. The next step after cloning, therefore, is to find and isolate that clone among other members of the library. If the library encompasses the whole genome of an organism, then somewhere within that library will be the desired clone. There are several ways of finding it, depending on the specific gene concerned. Most commonly, a cloned DNA segment that shows homology to the sought gene is used as a probe. For example, if a mouse gene has already been cloned, then that clone can be used to find the equivalent human clone from a human genomic library. Bacterial colonies constituting a library are grown in a collection of Petri dishes. Then a porous membrane is laid over the surface of each plate, and cells adhere to the membrane. The cells are ruptured, and DNA is separated into single strands—all on the membrane. The probe is also separated into single strands and labeled, often with radioactive phosphorus. A solution of the radioactive probe is then used to bathe the membrane. The single-stranded probe DNA will adhere only to the DNA of the clone that contains the equivalent gene. The membrane is dried and placed against a sheet of radiation-sensitive film, and somewhere on the films a black spot will appear, announcing the presence and location of the desired clone. The clone can then be retrieved from the original Petri dishes.

DNA sequencing
 Once a segment of DNA has been cloned, its nucleotide sequence can be determined. The nucleotide sequence is the most fundamental level of knowledge of a gene or genome. It is the blueprint that contains the instructions for building an organism, and no understanding of genetic function or evolution could be complete without obtaining this information.

      Knowledge of the sequence of a DNA segment has many uses, and some examples follow. First, it can be used to find genes, segments of DNA that code for a specific protein or phenotype. If a region of DNA has been sequenced, it can be screened for characteristic features of genes. For example, open reading frames (ORFs)—long sequences that begin with a start codon (three adjacent nucleotides; the sequence of a codon dictates amino acid production) and are uninterrupted by stop codons (except for one at their termination)—suggest a protein-coding region. Also, human genes are generally adjacent to so-called CpG islands—clusters of cytosine and guanine, two of the nucleotides that make up DNA. If a gene with a known phenotype (such as a disease gene in humans) is known to be in the chromosomal region sequenced, then unassigned genes in the region will become candidates for that function. Second, homologous DNA sequences of different organisms can be compared in order to plot evolutionary relationships both within and between species. Third, a gene sequence can be screened for functional regions. In order to determine the function of a gene, various domains can be identified that are common to proteins of similar function. For example, certain amino acid sequences within a gene are always found in proteins that span a cell membrane; such amino acid stretches are called transmembrane domains. If a transmembrane domain is found in a gene of unknown function, it suggests that the encoded protein is located in the cellular membrane. Other domains characterize DNA-binding proteins. Several public databases of DNA sequences are available for analysis by any interested individual.

      The two basic sequencing approaches are the Maxam-Gilbert method, discovered by and named for American molecular biologists Allan M. Maxam and Walter Gilbert (Gilbert, Walter), and the Sanger method, discovered by English biochemist Frederick Sanger (Sanger, Frederick). In the most commonly used method, the Sanger method, DNA chains are synthesized on a template strand, but chain growth is stopped when one of four possible dideoxy nucleotides, which lack a 3′ hydroxyl group, is incorporated, thereby preventing the addition of another nucleotide. A population of nested, truncated DNA molecules results that represents each of the sites of that particular nucleotide in the template DNA. These molecules are separated in a procedure called electrophoresis, and the inferred nucleotide sequence is deduced using a computer.

In vitro mutagenesis
      Another use of cloned DNA is in vitro mutagenesis in which a mutation is produced in a segment of cloned DNA. The DNA is then inserted into a cell or organism, and the effects of the mutation are studied. mutations are useful to geneticists in enabling them to investigate the components of any biological process. However, traditional mutational analysis relied on the occurrence of random spontaneous mutations—a hit-or-miss method in which it was impossible to predict the precise type or position of the mutations obtained. In vitro mutagenesis, however, allows specific mutations to be tailored for type and for position within the gene. A cloned gene is treated in the test tube (in vitro) to obtain the specific mutation desired, and then this fragment is reintroduced into the living cell, where it replaces the resident gene.

      One method of in vitro mutagenesis is oligonucleotide-directed mutagenesis. A specific point in a sequenced gene is pinpointed for mutation. An oligonucleotide, a short stretch of synthetic DNA of the desired sequence, is made chemically. For example, the oligonucleotide might have adenine in one specific location instead of guanine. This oligonucleotide is hybridized to the complementary strand of the cloned gene; it will hybridize despite the one base pair mismatch. Various enzymes are added to allow the oligonucleotide to prime the synthesis of a complete strand within the vector. When the vector is introduced into a bacterial cell and replicates, the mutated strand will act as a template for a complementary strand that will also be mutant, and thus a fully mutant molecule is obtained. This fully mutant cloned molecule is then reintroduced into the donor organism, and the mutant DNA replaces the resident gene.

      Another version of in vitro mutagenesis is gene disruption, or gene knockout. Here, the resident functional gene is replaced by a completely nonfunctional copy. The advantage of this technique over random mutagenesis is that specific genes can be knocked out at will, leaving all other genes untouched by the mutagenic procedure.

Genetically modified organisms (genetically modified organism)
      The ability to obtain specific DNA clones using recombinant DNA technology has made it possible to add the DNA of one organism to the genome of another. The added gene is called a transgene. The transgene inserts itself into a chromosome and is passed to the progeny as a new component of the genome. The resulting organism carrying the transgene is called a transgenic organism or a genetically modified organism (GMO). In this way, a “designer organism” is made that contains some specific change required for an experiment in basic genetics or for improvement of some commercial strain. Several transgenic plants have been produced. Genes for toxins that kill insects have been introduced in several species, including corn and cotton. Bacterial genes that confer resistance to herbicides also have been introduced into crop plants. Other plant transgenes aim at improving the nutritional value of the plant.

Gene therapy
      Gene therapy is the introduction of a normal gene into an individual's genome in order to repair a mutation that causes a genetic disease (genetic disease, human). When a normal gene is inserted into a mutant nucleus, it most likely will integrate into a chromosomal site different from the defective allele; although this may repair the mutation, a new mutation may result if the normal gene integrates into another functional gene. If the normal gene replaces the mutant allele, there is a chance that the transformed cells will proliferate and produce enough normal gene product for the entire body to be restored to the undiseased phenotype. So far, human gene therapy has been attempted only on somatic (body) cells for diseases such as cancer and severe combined immunodeficiency syndrome (SCIDS). Somatic cells cured by gene therapy may reverse the symptoms of disease in the treated individual, but the modification is not passed on to the next generation. Germinal gene therapy aims to place corrected cells inside the germ line (e.g., cells of the ovary or testis). If this is achieved, these cells will undergo meiosis and provide a normal gametic contribution to the next generation. Germinal gene therapy has been achieved experimentally in animals but not in humans.

Reverse genetics
      Recombinant DNA technology has made possible a type of genetics called reverse genetics. Traditionally, genetic research starts with a mutant phenotype, and, by Mendelian crossing analysis, a researcher is able to attribute the phenotype to a specific gene. Reverse genetics travels in precisely the opposite direction. Researchers begin with a gene of unknown function and use molecular analysis to determine its phenotype. One important tool in reverse genetics is gene knockout. By mutating the cloned gene of unknown function and using it to replace the resident copy or copies, the resultant mutant phenotype will show which biological function this gene normally controls.

Diagnostics (diagnosis)
      Recombinant DNA technology has led to powerful diagnostic procedures useful in both medicine and forensics. In medicine these diagnostic procedures are used in counseling prospective parents as to the likelihood of having a child with a particular disease, and they are also used in the prenatal prediction of genetic disease (genetic disease, human) in the fetus. Researchers look for specific DNA fragments that are located in close proximity to the gene that causes the disease of concern. These fragments, called restriction fragment length polymorphisms (RFLPs), often serve as effective “genetic markers.” In forensics, DNA fragments called variable number tandem repeats (VNTRs), which are highly variable between individuals, are employed to produce what is called a “DNA fingerprint (DNA fingerprinting).” A DNA fingerprint can be used to determine if blood or other body fluids left at the scene of a crime belongs to a suspect.

      The genetic analysis of entire genomes is called genomics. Such a broadscale analysis has been made possible by the development of recombinant DNA technology. In humans, knowledge of the entire genome sequence has facilitated searching for genes that produce hereditary diseases. It is also capable of revealing a set of proteins—produced at specific times, in specific tissues, or in specific diseases—that might be targets for therapeutic drugs. Genomics also allows the comparison of one genome with another, leading to insights into possible evolutionary relationships between organisms.

      Genomics has two subdivisions: structural genomics and functional genomics. Structural genomics is based on the complete nucleotide sequence of a genome. Each member of a library of clones is physically manipulated by robots and sequenced by automatic sequencing machines, enabling a very high throughput of DNA. The resulting sequences are then assembled by a computer into a complete sequence for every chromosome. The complete DNA sequence is scanned by computer to find the positions of open reading frames (ORFs), or prospective genes. The sequences are then compared to the sequences of known genes from other organisms, and possible functions are assigned. Some ORFs remain unassigned, awaiting further research.

      Functional genomics attempts to understand function at the broadest level (the genomic level). In one approach, gene functions of as many ORFs as possible are assigned as above in an attempt to obtain a full set of proteins encoded by the genome (called a proteome). The proteome broadly defines all the cellular functions used by the organism. Function in relation to specific developmental stages also is assessed by trying to identify the “transcriptome,” the set of mRNA transcripts made at specific developmental stages. The practical approach utilizes microarrays—glass plates the size of a microscope slide imprinted with tens of thousands of ordered DNA samples, each representing one gene (either a clone or a synthesized segment). The mRNA preparation under test is labeled with a fluorescent dye, and the microarray is bathed in this mRNA. Fluorescent spots appear on the array indicating which mRNAs were present, thus defining the transcriptome.

protein manufacture
      Recombinant DNA procedures have been used to convert bacteria into “factories” for the synthesis of foreign proteins. This technique is useful not only for preparing large amounts of protein for basic research but also for producing valuable proteins for medical use. For example, the genes for human proteins such as growth hormone, insulin, and blood-clotting factor can be commercially manufactured. Another approach to producing proteins via recombinant DNA technology is to introduce the desired gene into the genome of an animal, engineered in such a way that the protein is secreted in the animal's milk, facilitating harvesting.

Anthony J.F. Griffiths

* * *

Universalium. 2010.